http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2493316-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c4cb9b5558ad97d3acc0db1113f7727
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096
filingDate 1980-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a33403de2826f0332961c92539fc5847
publicationDate 1982-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2493316-A1
titleOfInvention NEW PROCESS FOR THE PREPARATION OF (TRIALCOXY BENZYL) -1 PIPERAZINES AND IN PARTICULAR (TRIMETHOXY-2 ', 3', 4 'BENZYL) -1 PIPERAZINE
abstract THE INVENTION CONCERNS THE PREPARATION OF (TRIALCOXY BENZYL) -1 PIPERAZINES AND IN PARTICULAR (TRIMETHOXY-2, 3, 4 BENZYL) -1 PIPERAZINE. THE PROCESS CONSISTS OF PREPARING, IN A FIRST PHASE, THE PIPERAZINONE-2 CORRESPONDING TO THE SAID PIPERAZINE, THEN REDUCING, IN A SECOND PHASE, THE SAID PIPERAZINONE. MORE PARTICULARLY, IN THE FIRST PHASE, A MOLE OF A TRIALCOXY BENZYL CHLORIDE IS REACTED IN A FIRST SOLVENT ON TWO MOLES OF PIPERAZINONE-2 TO OBTAIN A TRIALCOXY BENZYL-4 PIPERAZINONE-2 AND, IN THE SECOND PHASE, THIS LATTER COMPOUND IS REDUCED IN A SECOND SOLVENT BY MEANS OF A HYDRIDE. PREFERREDLY THE FIRST SOLVENT IS TOLUENE, THE SECOND SOLVENT TETRAHYDROFURANE AND LEDIT HYDRIDE ALLIH OR BH.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0617027-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2661176-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5142053-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2703048-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100413854-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0453365-A1
priorityDate 1980-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421334983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID231360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414870915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449445756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420313929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559594

Total number of triples: 45.